tislelizumab-jsgr
Tevimbra Approved for Some Patients With Unresectable or Metastatic ESCC
The FDA has approved Tevimbra, in combination with platinum-containing chemotherapy, for the first-line treatment ...
MARCH 4, 2025
Tevimbra Approved for Treatment of Gastric and Gastroesophageal Junction Cancers in Combination With Chemo
The FDA has approved Tevimbra, in combination with platinum and fluoropyrimidine-based chemotherapy, for the ...
JANUARY 13, 2025
Tevimbra Approved for Advanced or Metastatic Esophageal Squamous Cell Carcinoma After Prior Chemo
The FDA approved Tevimbra as monotherapy for adult patients with unresectable or metastatic esophageal squamous ...
MARCH 20, 2024
Load more